A
Arecor Therapeutics PLC
LSE:AREC
Arecor Therapeutics PLC
LSE:AREC
Price:
131 GBX
Market Closed
Updated:
May 19, 2024
Arecor Therapeutics PLC
EPS (Diluted)
|
Arecor Therapeutics PLC
EPS (Diluted) Peer Comparison
Comparables:
CNTA
AUTL
BCYC
IMCR
GNS
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
A
|
Arecor Therapeutics PLC
LSE:AREC
|
EPS (Diluted)
£0
|
CAGR 3-Years
-86%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
|
EPS (Diluted)
-$1
|
CAGR 3-Years
-136%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Autolus Therapeutics PLC
NASDAQ:AUTL
|
EPS (Diluted)
-$1
|
CAGR 3-Years
24%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bicycle Therapeutics PLC
NASDAQ:BCYC
|
EPS (Diluted)
-$3
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
N/A
|
|
|
Immunocore Holdings PLC
NASDAQ:IMCR
|
EPS (Diluted)
-£1
|
CAGR 3-Years
14%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
|
Genus PLC
LSE:GNS
|
EPS (Diluted)
£0
|
CAGR 3-Years
-8%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
2%
|
See Also
What is Arecor Therapeutics PLC's EPS (Diluted)?
EPS (Diluted)
-0.3
GBP
-0.3
GBP
Based on the financial report for Dec 31, 2022, Arecor Therapeutics PLC's EPS (Diluted) amounts to -0.3 GBP.
What is Arecor Therapeutics PLC's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 3Y
-86%
-86%
Over the last year, the EPS (Diluted) growth was -19%. The average annual EPS (Diluted) growth rates for Arecor Therapeutics PLC have been -86% over the past three years .
You don't have any saved screeners yet
